Current Report Filing (8-k)
19 Mayo 2023 - 3:03PM
Edgar (US Regulatory)
false
0001644903
0001644903
2023-05-17
2023-05-17
0001644903
ycbd:CommonCustomMember
2023-05-17
2023-05-17
0001644903
ycbd:SeriesACumulativeConvertiblePreferredStock80CustomMember
2023-05-17
2023-05-17
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) May 17, 2023
cbdMD, INC.
(Exact name of registrant as specified in its charter)
|
North Carolina
|
001-38299
|
47-3414576
|
|
(State or other jurisdiction of incorporation or organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
8845 Red Oak Blvd, Charlotte, NC 28217
(Address of principal executive offices)(Zip Code)
Registrant's telephone number, including area code: (704) 445-3060
________________________________
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
common
|
YCBD
|
NYSE American
|
|
8.0% Series A Cumulative Convertible Preferred Stock
|
YCBDpA
|
NYSE American
|
Indicate by check mark whether the registrant is an emerging growth company as defined in in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☑
If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
On May 17, 2023, cbdMD, Inc. declared a monthly cash dividend to holders of our 8.0% Series A Cumulative Convertible Preferred Stock, par value $0.001 per share (the “Series A Convertible Preferred Stock”). The dividend of $0.0667 per share of Series A Convertible Preferred Stock is payable on June 15, 2023 to holders of record on June 1, 2023.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
cbdMD, Inc.
|
| |
|
|
|
Date: May 19, 2023
|
By:
|
/s/ T. Ronan Kennedy
|
| |
|
T. Ronan Kennedy, Interim CEO and Chief Financial Officer
|
cbdMD (AMEX:YCBD)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
cbdMD (AMEX:YCBD)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024
